Daoxun Chen

机构：Fujian Medical University, First Affiliated Hospital of Fujian Medical University, Sanming University

发表论文 7 篇 · 总被引 15 次 · h-index 3

代表论文

• CDCA3 Predicts Poor Prognosis and Affects CD8+ T Cell Infiltration in Renal Cell Carcinoma (2022 · Journal of Oncology · 被引 7)
• Amiloride reduces fructosamine-3-kinase expression to restore sunitinib sensitivity in renal cell carcinoma (2024 · iScience · 被引 5)
• Validation of prognostic signature and exploring the immune-related mechanisms for NR3C2 in clear cell renal cell carcinoma (2023 · Translational Cancer Research · 被引 3)
• MP10-01 CD73 BLOCKADE POTENTIATES FH-CGAS-STING AXIS IN THE MICROENVIRONMENT OF RENAL CELL CARCINOMA (2024 · The Journal of Urology)
• Amiloride Reduces FN3K Expression to Restore Sunitinib Sensitivity in Renal Cell Carcinoma (2023 · SSRN Electronic Journal)
• Chemotherapy, Immunotherapy, and Surgery Should be Optimal Treatment Choices of Metastatic Sarcomatoid Renal Cell Carcinoma (2022 · Research Square)